Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • Singapore Stocks
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ensysce Biosciences Inc.

2.09
+0.01000.48%
Pre-market: 2.00-0.0900-4.31%07:34 EDT
Volume:14.99M
Turnover:37.41M
Market Cap:4.95M
PE:-0.18
High:2.37
Open:2.30
Low:1.95
Close:2.08
Loading ...
OverviewCompanyNewsFilings

Concept

no data

No relevant data is available

Capital Flow

 
Inflow:
 
Outflow:
 
 
 
 
 
 
 
 
 
 
 
 
 
 

News

Ensysce Biosciences Secures FDA Breakthrough Therapy Designation and Advances Regulatory Review for Opioid with Overdose Protection, Supported by NIDA Grants

Reuters
·
Yesterday

Ensysce Biosciences Inc. Unveils Presentation on 'Next Generation Opioids' Targeting Severe Pain with Innovative Abuse-Protection Technologies

Reuters
·
18 Jul

Ensysce Biosciences initiates Phase 3 study of PF614

TIPRANKS
·
16 Jul

Ensysce Biosciences Launches Pivotal Phase 3 Study of PF614, Aiming to Redefine Pain Therapy with Reduced Abuse Risk

Reuters
·
16 Jul

Analyst Rate

 
 
 
 

Corporate Actions

Financial Report Announcement
May 13, 2025 Post Market
Financial Report Announcement
Mar 10, 2025 Post Market
Split&Reverse Split
Dec 06, 2024 15 for 1
Financial Report Announcement
Nov 12, 2024 Post Market
Financial Report Announcement
Aug 14, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.72
Current
-9.90
Sector Average
30.45%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.72
Maximum
2,051.95
+1 STD
280.72
Minimum
-1,102.75
-1 STD
-300.52
Average
-9.90

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.